as always, anything is possible but that doesn't really make sense to me. The FDA has cleared the IND to move forward. While it is possible the IRB at a site or sites is in need of more info or something of that nature, I can't see the FDA causing the delay at this stage ,that describes a clinical hold prior to starting trial.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.